These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2474542)

  • 41. T-cell antigenic sites tend to be amphipathic structures.
    DeLisi C; Berzofsky JA
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7048-52. PubMed ID: 2413457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
    Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
    Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disruption of structural and functional integrity of alpha 2-macroglobulin by cathepsin E.
    Shibata M; Sakai H; Sakai E; Okamoto K; Nishishita K; Yasuda Y; Kato Y; Yamamoto K
    Eur J Biochem; 2003 Mar; 270(6):1189-98. PubMed ID: 12631277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.
    Bhayani H; Paterson Y
    J Exp Med; 1989 Nov; 170(5):1609-25. PubMed ID: 2553848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Redesign of the substrate specificity of human cathepsin D: the dominant role of position 287 in the S2 subsite.
    Scarborough PE; Dunn BM
    Protein Eng; 1994 Apr; 7(4):495-502. PubMed ID: 7913221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Substrate specificity of cathepsins D and E determined by N-terminal and C-terminal sequencing of peptide pools.
    Arnold D; Keilholz W; Schild H; Dumrese T; Stevanović S; Rammensee HG
    Eur J Biochem; 1997 Oct; 249(1):171-9. PubMed ID: 9363769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cloning and sequence analysis of cDNA for human cathepsin D.
    Faust PL; Kornfeld S; Chirgwin JM
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):4910-4. PubMed ID: 3927292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular cloning and expression of ovarian cathepsin D in seabream, Sparus aurata.
    Carnevali O; Centonze F; Brooks S; Marota I; Sumpter JP
    Biol Reprod; 1999 Sep; 61(3):785-91. PubMed ID: 10456857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular cloning and functional characterization of chicken cathepsin D, a key enzyme for yolk formation.
    Retzek H; Steyrer E; Sanders EJ; Nimpf J; Schneider WJ
    DNA Cell Biol; 1992 Nov; 11(9):661-72. PubMed ID: 1418623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hydrolytic specificity of the barley grain aspartic proteinase.
    Kervinen J; Sarkkinen P; Kalkkinen N; Mikola L; Saarma M
    Phytochemistry; 1993 Mar; 32(4):799-803. PubMed ID: 7763475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The complete amino acid sequence of bovine cathepsin S and a partial sequence of bovine cathepsin L.
    Ritonja A; Colić A; Dolenc I; Ogrinc T; Podobnik M; Turk V
    FEBS Lett; 1991 Jun; 283(2):329-31. PubMed ID: 2044774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mapping the T cell epitopes of the Babesia bovis antigen 12D3: implications for vaccine design.
    Court RA; Sitte K; Opdebeeck JP; East IJ
    Parasite Immunol; 1998 Jan; 20(1):1-8. PubMed ID: 9491412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing.
    Dahl SW; Halkier T; Lauritzen C; Dolenc I; Pedersen J; Turk V; Turk B
    Biochemistry; 2001 Feb; 40(6):1671-8. PubMed ID: 11327826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Processing of the pre-beta-amyloid protein by cathepsin D is enhanced by a familial Alzheimer's disease mutation.
    Dreyer RN; Bausch KM; Fracasso P; Hammond LJ; Wunderlich D; Wirak DO; Davis G; Brini CM; Buckholz TM; König G
    Eur J Biochem; 1994 Sep; 224(2):265-71. PubMed ID: 7523115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of a pre-selected epitope of cathepsin-L1 in a highly specific peptide-based immunoassay for the diagnosis of Fasciola hepatica infections in cattle.
    Cornelissen JB; Gaasenbeek CP; Boersma W; Borgsteede FH; van Milligen FJ
    Int J Parasitol; 1999 May; 29(5):685-96. PubMed ID: 10404262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.
    Glondu M; Coopman P; Laurent-Matha V; Garcia M; Rochefort H; Liaudet-Coopman E
    Oncogene; 2001 Oct; 20(47):6920-9. PubMed ID: 11687971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proteolytic activation of human procathepsin D.
    Richo G; Conner GE
    Adv Exp Med Biol; 1991; 306():289-96. PubMed ID: 1812719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation.
    Hsieh CS; deRoos P; Honey K; Beers C; Rudensky AY
    J Immunol; 2002 Mar; 168(6):2618-25. PubMed ID: 11884425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration.
    Kenessey A; Nacharaju P; Ko LW; Yen SH
    J Neurochem; 1997 Nov; 69(5):2026-38. PubMed ID: 9349548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1.
    Zamorano PI; Wigdorovitz A; Pérez Filgueira DM; Escribano JM; Sadir AM; Borca MV
    Vaccine; 1998 Apr; 16(6):558-63. PubMed ID: 9569465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.